Skip to main content
Download PDF

Interaction between HTR2A rs3125 and negative life events in suicide attempts among patients with major depressive disorder: a cross-sectional study

BMC Psychiatry volume 24, Article number: 249 (2024) Cite this article

Abstract

Background

Both genetic and environmental factors play crucial roles in the development of major depressive disorder (MDD) and suicide attempts (SA). However, the interaction between both items remains unknown. This study aims to explore the interactions between the genetic variants of the serotonin 2 A receptor (HTR2A) and the nitric oxide synthase 1 (NOS1) and environmental factors in patients who experience MDD and SA.

Methods

A total of 334 patients with MDD and a history of SA (MDD-SA) were recruited alongside 518 patients with MDD with no history of SA (MDD-NSA), and 716 healthy controls (HC). The demographic data and clinical characteristics were collected. Sequenom mass spectrometry was used to detect eight tag-single nucleotide polymorphisms (tagSNPs) in HTR2A (rs1328683, rs17068986, and rs3125) and NOS1 (rs1123425, rs2682826, rs3741476, rs527590, and rs7959232). Generalized multifactor dimensionality reduction (GMDR) was used to analyze the gene-environment interactions.

Results

Four tagSNPs (rs17068986, rs3125, rs527590, and rs7959232) exhibited significant differences between the three groups. However, these differences were not significant between the MDD-SA and MDD-NSA groups after Bonferroni correction. A logistic regression analysis revealed that negative life events (OR = 1.495, 95%CI: 1.071–2.087, P = 0.018), self-guilt (OR = 2.263, 95%CI: 1.515–3.379, P < 0.001), and negative cognition (OR = 2.252, 95%CI: 1.264–4.013, P = 0.006) were all independently associated with SA in patients with MDD. Furthermore, GMDR analysis indicated a significant interaction between HTR2A rs3125 and negative life events. Negative life events in conjunction with the HTR2A rs3125 CG + GG genotype were associated with a higher SA risk in patients with MDD when compared to the absence of negative life events in conjunction with the CC genotype (OR = 2.547, 95% CI: 1.264–5.131, P = 0.009).

Conclusion

Several risk factors and a potential interaction between HTR2A rs3125 and negative life events were identified in patients with SA and MDD. The observed interaction likely modulates the risk of MDD and SA, shedding light on the pathogenesis of SA in patients with MDD.

Peer Review reports

Introduction

Major depressive disorder (MDD) and suicide attempts (SA) are significant public health issues worldwide due to their high prevalence and incidence rates. Approximately 800,000 people die from suicide globally each year, marking a distressing trend of increasing suicide rates over the past 20 years [1,2,3]. Notably, over 90% of people who die from suicide are reported to have some form of mental disorder, with MDD being especially prominent [4]. Suicide is considered the most serious consequence of MDD [5, 6]. Previous studies have demonstrated that patients with MDD and a history of SA have a higher risk of dying from suicide compared to those with no history of SA [7,8,9]. Thus, there is an urgent need to define the risk factors and pathogenesis of SA. This effort will enable earlier identification and intervention in patients with MDD exhibiting suicidal behaviors.

Genetic factors play a crucial role in MDD [10, 11]. Population-based studies have confirmed that the heritability of MDD is 30–40% [12], with the corresponding suicide risk also having genetic characteristics [13]. Notably, studies have demonstrated that genetic susceptibility to MDD increases the risk of suicide [14, 15]. Many biological factors and candidate genes have been associated with MDD and SA [16, 17], including the serotonin 2 A receptor (HTR2A) gene and the nitric oxide synthase 1 (NOS1) gene. There is evidence indicating that the density of HTR2A is increased in brain regions of depressed suicide patients [18, 19]. Hrdina et al. observed that platelet HTR2A was significantly up-regulated in patients with MDD who have suicidal thoughts compared to patients without suicidal thoughts. They further noted that the elevated HTR2A levels persisted even after antidepressant treatment [20]. Several studies have also suggested an association between NOS genes and suicidal behavior [21, 22], with a lack of NOS1 resulting in increased impulsivity, aggression, and other abnormal social behaviors. A study revealed lower NOS protein levels in the brain tissue of patients with MDD who died by suicide compared to the normal control group [23]. Additionally, lower levels of NOS1 mRNA have been observed in the anterior cingulate cortex of patients with MDD [24, 25]. Thus, HTR2A and NOS1 genes may play a crucial role in determining whether individuals with MDD may attempt suicide.

Increasing evidence supports the involvement of both heritable and environmental risk factors in MDD and SA [26,27,28]. Environmental factors, including early trauma and recent acute/chronic stress (separation, loss, interpersonal or family problems, poor social contacts/support, and occupational stress/unemployment), have long been recognized to play pivotal roles in both MDD development and SA [6, 29, 30]. Gene-environment investigations have consistently revealed HTR2A to be associated with both MDD and SA and have yielded conflicting results. Notably, rs6313 demonstrated some level of interaction with both MDD [28] and suicidal behavior [31, 32]. However, this finding was not consistent across several studies [32, 33]. A study revealed an interaction between rs6311 (–1438G > A) and a measure of familial environment in MDD [34]. Another study reported three variants (rs6561333, rs7997012, and rs1885884) of HTR2A that interact with early trauma in association with SA but not with MDD [35]. This inconsistency may be due to varied forms of measurement of environmental risk. However, there is currently a lack of research on the interaction between NOS1 and environmental factors in patients with SA and MDD.

In this study, it was hypothesized that the interaction between genetic variants of HTR2A and NOS1 and environmental factors plays a crucial role in the development of suicidal behavior in patients with MDD. Therefore, this study aims to explore the associations among the HTR2A gene, NOS1 gene, and environmental factors in patients with MDD who have a history of SA.

Methods

Subjects

Patients with MDD were recruited from the First Affiliated Hospital of Zhengzhou University over the period from 2009 to 2014. The inclusion criteria were as follows: (1) meeting the diagnostic criteria for MDD as specified by the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV); (2) presenting a score ≥ 21 on the Hamilton Depression Rating Scale-24 items (HDRS-24); (3) being 18 to 65 years of age; and (4) being of Han Chinese ethnicity. The following exclusion criteria were used: (1) presenting with comorbid psychotic illness; (2) having a family history of inherited diseases; (3) having organic mental disorders; and (4) having psychoactive substance abuse.

Healthy controls (HC) from the Physical Examination Center of the First Affiliated Hospital of Zhengzhou University were enrolled as the control group. Inclusion criteria for healthy controls consisted of (1) having no family history of mental disorders; (2) having an HDRS-24 score of < 7; (3) being aged 18 years to 65 years; and (4) being of Han Chinese ethnicity. Individuals with family histories of inherited diseases or psychoactive substance abuse were excluded.

A total of 852 patients with MDD and 716 HC were included in this study. SA was defined as suicidal behaviors associated with the intention to end one’s own life but not leading to death. In the clinical interview, all subjects and/or their guardians or other persons with whom they had lived for an extended period were asked “In your (or the patient’s) course of MDD, did you (he or she) ever attempt suicide?” If the participant answered “yes,” these patients were regarded as having a history of SA. Negative life events were collected by asking “Did you (he or she) experience unemployment, separation, loss, interpersonal or family problems before SA?” If they answered “yes”, negative life events are recorded as “Yes”, otherwise as “No”. Childhood trauma history was collected by asking “Did you (he or she) experience sexual or physical abuse before SA?” If they answered “yes”, childhood trauma history was recorded as “Yes”, otherwise as “No”.

To reduce recall bias, patient data were collected and verified by their guardians or other people with whom they had lived for an extended period. The patients were divided into MDD-SA and MDD-NSA groups based on whether they had a history of SA during the overall course of MDD. This study was approved by the Ethics Committee of the First Affiliated Hospital of Zhengzhou University and all participants signed an informed consent form before they participated in the study.

Clinical data

The clinical data obtained from the study participants included sociodemographic data and clinical features. The diagnosis was confirmed using the Structured Clinical Interview for DSM-IV Axis I. Sociodemographic data were collected using a self-designed demographic questionnaire, and the items of the HDRS-24 were applied to assess symptom severity. Sociodemographic data included six variables: sex, age, marital status, childhood trauma history, family history of psychosis, and negative life events. The clinical features included 13 variables: age at onset, number of episodes, overall course of illness, depressive symptoms (including depressed mood, loss of interest, lack of energy, self-guilt, negative cognition, weight loss, circadian rhythms, waking up early, sexual dysfunction, and psychotic symptoms). Date for family history of psychosis and depressive symptoms were collected by asking “Did you have a family history of psychosis or depressive symptoms?” Based on the answer, they were recorded as “Yes” or “No”. To reduce sampling bias, the research team members were trained in clinical diagnosis, scale evaluation, and clinical interviews, and a consistency test was conducted.

TagSNPs data

Using data from the NCBI database (HapMap Data Rel 28Phase II + III, August 10, NCBI B36 assembly, dbSNP bl26-CHB + JPT data), specific single nucleotide polymorphisms (SNPs) of HTR2A and NOS1 were selected for analysis. The Haploview 4.2 software was used to select eligible tag-single nucleotide polymorphisms (tagSNPs), with minimum allele frequency (MAF) > 0.05 and r2 ≥ 0.8 as the selection conditions. The subjects’ DNA was extracted using TIANGEN’s DP348-3 whole blood genomic DNA extraction kit. The DNA samples were collected by silica gel membrane adsorption and subsequently genotyped. Eight tagSNPs (rs1328683, rs17068986, and rs3125 in HTR2A and rs1123425, rs2682826, rs3741476, rs527590, and rs7959232 in NOS1) were detected using Sequenom mass spectrometry (see Additional file 1). The genotypes of the eight tagSNPs in the three groups were consistent with the H-W balance law (P > 0.05).

Statistical analysis

Statistical Package for the Social Sciences (SPSS version 25) was used to analyze the data. Continuous variables with normal distribution were analyzed using independent t-tests or one-way analysis between two or three groups, with results presented as mean ± standard deviation (SD). Conversely, continuous variables deviating from normal distribution were subjected to non-parametric tests, and outcomes were reported as median (interquartile range). The chi-square test was employed for qualitative variables, and Bonferroni correction was applied for multiple comparisons. Logistic regression analysis was conducted to examine the factors that significantly influenced SA in patients with MDD.

Gene-environment interactions were analyzed using the generalized multifactor dimensionality reduction (GMDR) [36] BetaV0.7 software package. Gene-environment interactions can reflect a causal mechanism where one or more environmental factors contribute to the causation of a condition in the same individual with genetic factors influencing the sensitivity to environmental exposures. The best gene-environment interaction model was selected based on the values obtained from cross-validation (CV) consistency and accuracy testing. Odds ratios (OR) were computed with a 95% confidence interval (CI) using logistic regression to determine the set of risk factors identified by the GMDR analysis. A two-sided analysis was performed, with the threshold for statistical significance set at P < 0.05. However, the threshold for statistical significance after Bonferroni correction was set at P = 0.0167.

Results

Sociodemographic data and clinical features

A total of 334 out of 852 patients with MDD had a history of SA (Additional file 2). The SA rate was 39.2%. There were no significant differences between the three groups in terms of mean age (F = 0.433, P = 0.805) or sex (χ2 = 4.595, P = 0.101). The MDD-SA and MDD-NSA groups differed significantly in terms of negative life events (χ2 = 8.63, P = 0.004), lack of energy (χ2 = 5.46, P = 0.019), self-guilt (χ2 = 38.58, P = 0.000), negative cognition (χ2 = 10.01, P = 0.002), weight loss (χ2 = 6.61, P = 0.010), and circadian rhythms (χ2 = 9.20, P = 0.003).

Eight tagSNPs of MDD-SA vs. MDD-NSA vs. HC

Significant differences were observed in the genotype and allele frequencies of HTR2A rs17068986 (χ2 = 13.892, P = 0.008) and rs3125 (χ2 = 13.992, P = 0.007), as well as NOS1 rs527590 (χ2 = 13.330, P = 0.010) and rs7959232 (χ2 = 13.636, P = 0.009) among the three groups (Additional file 3). Bonferroni correction for further pairwise comparisons revealed no statistical differences in genotype or allele frequencies between the MDD-SA and MDD-NSA groups (P > 0.0167). Statistical differences only existed between the MDD-SA and HC groups or the MDD-NSA and HC groups (P < 0.0167).

The risk factors for SA in patients with MDD

Ten variables exhibiting statistical differences (Additional file 2 and Additional file 3) were included in the multifactor logistic regression analysis to identify the risk factors for SA in patients with MDD. Negative life events (OR = 1.495, 95% CI: 1.071–2.087, and P = 0.018), self-guilt (OR = 2.263, 95% CI: 1.515–3.379, and P = 0.000), and negative cognition (OR = 2.525, 95% CI: 1.264–4.013, and P = 0.006) were all independently associated with SA in patients with MDD (Table 1).

Table 1 Risk factors for SA in patients with MDD
Full size table

The gene-environment interaction for SA in patients with MDD

Four tagSNPs (HTR2A rs27068986 and rs3125, NOS1 rs527590 and rs7959232) exhibiting statistical differences (Additional file 3) and environmental factors (childhood trauma history and negative life events) were incorporated into the GMDR to analyze the gene-environment interactions for SA in patients with MDD. Table 2 summarizes the results obtained from the GMDR analyses of one- to six-locus models. There was a significant two-locus model (P = 0.011) involving rs3125 and negative life events, indicating a potential gene-environment interaction between rs3125 and negative life events. The two-locus models had a test accuracy of 0.578 and a cross-validation consistency of 10/10. Figure 1 depicts the detailed gene-environment interactions between HTR2A rs3125 and negative life events. Participants with the GG genotype of rs3125 and negative life events were at a highest risk for SA with the highest sum score.

Table 2 Gene-environment interaction among 4 tagSNPs, childhood trauma history, and negative life events
Full size table
Fig. 1
figure 1

Analysis of gene-environment interactions between HTR2A rs3125 and negative life events using GMDR. The dark gray cell represents the high risk factors and the light gray cell represents the low risk factors. The left and right columns represent the maximum likelihood estimates of the weights for the MDD-SA and MDD-NSA groups, and are expressed as positive and negative scores. The sum of positive and negative score is used to judge the high or low risk of the combination. NO and YES denote no negative life events and have negative life events, respectively. Among them, individuals with GG genotype of rs3125 when exposed negative life events had the highest SA risk with the highest sum score. HTR2A, serotonin 2 A receptor; GMDR, generalized multifactor dimensionality reduction; MDD-SA group, major depressive depression with suicide attempts; MDD-NSA group, major depressive depression without suicide attempt

Full size image

OR and 95% CI were obtained for the set of risk factors identified from the GMDR analysis to further assess the identified gene-environment interactions associated with SA in MDD. To narrow down the number of possible combinations, we used the combination of CC genotype of rs3125 and non-negative events as the reference group. Notably, negative life events, together with the CG + GG genotype were significantly associated with SA in patients with MDD compared to non-negative life events for those with the CC genotype (OR = 2.547, 95% CI: 1.264–5.131, P = 0.009) (Table 3).

Table 3 Interaction between HTR2A rs3125 genotype and negative life events for SA in patients with MDD
Full size table

Discussion

In this study, we investigated the risk factors and interaction of polymorphisms in two genes, along with environmental factors in relation to SA in patients with MDD. Three risk factors were identified for SA in patients with MDD: negative life events, self-guilt, and negative cognition. Two-locus models were also found between HTR2A rs3125 and negative life events in relation to SA in patients with MDD. The combination of negative life events and HTR2A rs3125 CG + GG genotype was associated with a higher SA risk in patients with MDD. These findings are consistent with those of previous studies indicating that genes affect the development of suicidal behavior and MDD not only through direct effects on MDD risk but also by modulating individuals’ sensitivity to environmental factors.

Both MDD and SA have genetic predispositions. Several studies have suggested a relationship between HTR2A and NOS1 genes and SA in patients with MDD [35, 37,38,39,40,41]. However, the results obtained have been inconsistent. This present study revealed significant differences in the four tagSNPs—rs17068986 and rs3125 of HTR2A, as well as rs527590 and rs7959232 of NOS1—across the MDD-SA, MDD-NSA, and HC groups. However, none of the associations retained statistical significance upon applying the Bonferroni correction test. Consistent with the results of this study, previous studies also reported no association between the tagSNPs of the HTR2A gene and SA in patients with MDD [42,43,44,45]. A study involving French adolescents suggested that rs2682826 of NOS1 was not associated with SA [46], consistent with the results of our study. However, several studies have reported inconsistent results in this area [40, 47, 48]. A study in Japan revealed that rs2682826 of NOS1 was associated with completed suicides, especially in male patients [48]. However, the association between genes and SA in patients is inconsistent. A major reason for these inconsistent findings is that both MDD and SA are complex, heterogeneous diseases caused by a combination of multiple gene variants, each of which has only a small impact on disease risk and symptoms.

This study also revealed that symptoms of self-guilt, negative cognition, and negative life events were associated with increased suicide risk in patients with MDD, consistent with the findings of previous studies [49,50,51]. In a multi-ethnic Asian population study, patients with repeated SA reported having experienced a greater level of adverse life events such as unemployment, divorce, quarrels, and negative emotions [49]. A meta-analysis revealed that SA in patients with MDD was associated with more severe depressive symptoms and hopelessness [50]. A case-control study also demonstrated that hopelessness and negative life events are risk factors for SA in patients with MDD [51]. However, this present study did not identify significant associations between SA and other risk factors such as sex, family history of psychosis [50], early age of onset [52, 53], and psychosis [54]. These differences may be attributable to different social cultures, methods, and differences in the characteristics of the enrolled participants. Environmental factors have also been demonstrated to play a crucial role in SA [6, 30, 55].

However, the exact pathogenesis underlying SA in patients with MDD remains unclear. Several studies have reported gene-environment interactions in suicidal patients with MDD [6, 35, 39]. In a 22-year longitudinal gene-environment study, HTR2A variants (rs6561333, rs7997012, and rs1885884) were noted to interact with histories of sexual and physical abuse in patients with SA [35]. Early adversity and recent acute/chronic stress (separation, loss, interpersonal or family questions, and unemployment) have long been recognized as playing a critical role in both MDD and SA [6, 56].To the best of our knowledge, this is the first study on the interaction between HTR2A rs3125 and negative life events using the GMDR model in a Chinese population. Notably, this study identified a potential gene-environment interaction between HTR2A rs3125 and negative life events in relation to SA in patients with MDD. This finding supports the hypothesis that MDD and SA result from a combination of genetic and environmental factors.

This study is subject to several limitations. First, the study focused on the Chinese population, and the results may not apply to other countries. Second, the data used in this study were collected retrospectively. Therefore, a recall bias may have affected the accuracy of the data. However, only a step was taken to reduce the likelihood of recall bias. Third, the environmental factors and clinical features were only qualitatively analyzed as binary data. In future studies, questionnaire evaluations should be conducted to quantitatively assess these variables.

Conclusions

A potential interaction was identified between HTR2A rs3125 and negative life events by GMDR. This interaction reflects a higher risk of SA when patients with MDD carrying the rs3125 GG genotype of HTR2A are exposed to negative life events. Therefore, this study may not only provide evidence of certain key risk factors for SA in patients with MDD but may also deepen our understanding of its pathogenesis.

Data availability

The datasets used and/or analyzed during the current study will be made available upon reasonable request. Raw data supporting the obtained results are available at the corresponding author.

Abbreviations

MDD:

Major depressive disorder

SA:

Suicide attempts

HTR2A:

Serotonin 2 A receptor

NOS1:

Nitric oxide synthase 1

tagSNPs:

Tag-single nucleotide polymorphisms

GMDR:

Generalized multifactor dimensionality reduction

MDD-SA:

Major depressive depression with suicide attempts

MDD-NSA:

Major depressive depression without suicide attempts

HC:

Healthy controls

OR:

Odds ratios

CI:

Confidence interval

DSM-IV:

Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition

HDRS-24:

Hamilton Depression Rating Scale-24 items

CV:

Cross-validation

NLE:

Negative life events

CTH:

Childhood trauma history

References

  1. Hedegaard H, Curtin SC, Warner M. Increase in suicide mortality in the United States, 1999–2018. NCHS Data Brief 2020(362):1–8.

  2. Pettrone K, Curtin SC. Urban-rural differences in suicide rates, by sex and three leading methods: United States, 2000–2018. NCHS Data Brief 2020(373):1–8.

  3. Stone DM, Simon TR, Fowler KA, Kegler SR, Yuan KM, Holland KM, Ivey-Stephenson AZ, Crosby AE. Vital signs: Trends in state suicide Rates - United States, 1999–2016 and circumstances contributing to Suicide-27 States, 2015. Mmwr-Morbid Mortal W. 2018;67(22):617–24.

    Article  Google Scholar 

  4. Dong M, Zeng LN, Lu L, Li XH, Ungvari GS, Ng CH, Chow IHI, Zhang L, Zhou Y, Xiang YT. Prevalence of suicide attempt in individuals with major depressive disorder: a meta-analysis of observational surveys. Psychol Med. 2019;49(10):1691–704. https://doi.org/10.1017/S0033291718002301.

    Article  PubMed  Google Scholar 

  5. Paljarvi T, Tiihonen J, Lateenvuo M, Tanskanen A, Fazel S, Taipale H. Psychotic depression and deaths due to suicide. J Affect Disorders. 2023;321:28–32. https://doi.org/10.1016/j.jad.2022.10.035.

    Article  PubMed  Google Scholar 

  6. Mandelli L, Serretti A. Gene environment interaction studies in depression and suicidal behavior: an update. Neurosci Biobehav Rev. 2013;37(10 Pt 1):2375–97. https://doi.org/10.1016/j.neubiorev.2013.07.011.

    Article  PubMed  Google Scholar 

  7. Suominen K, Isometsa E, Suokas J, Haukka J, Achte K, Lonnqvist J. Completed suicide after a suicide attempt: a 37-year follow-up study. Am J Psychiatry. 2004;161(3):562–3. https://doi.org/10.1176/appi.ajp.161.3.562.

    Article  PubMed  Google Scholar 

  8. Kuo WH, Gallo JJ. Completed suicide after a suicide attempt. Am J Psychiatry. 2005;162(3):633. https://doi.org/10.1176/appi.ajp.162.3.633.

    Article  PubMed  Google Scholar 

  9. Chiu CC, Liu HC, Li WH, Tsai SY, Chen CC, Kuo CJ. Incidence, risk and protective factors for suicide mortality among patients with major depressive disorder. Asian J Psychiatr. 2023, 80. https://doi.org/10.1016/j.ajp.2022.103399.

  10. Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry. 2000;157(10):1552–62. https://doi.org/10.1176/appi.ajp.157.10.1552.

    Article  CAS  PubMed  Google Scholar 

  11. Kendler KS, Gatz M, Gardner CO, Pedersen NL. A Swedish national twin study of lifetime major depression. Am J Psychiatry. 2006;163(1):109–14. https://doi.org/10.1176/appi.ajp.163.1.109.

    Article  PubMed  Google Scholar 

  12. Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ. Familial influences on the clinical characteristics of Major Depression - a Twin Study. Acta Psychiat Scand. 1992;86(5):371–8. https://doi.org/10.1111/j.1600-0447.1992.tb03283.x.

    Article  CAS  PubMed  Google Scholar 

  13. McGuffin P, Perroud N, Uher R, Butler A, Aitchison KJ, Craig I, Lewis C, Farmer A. The genetics of affective disorder and suicide. Eur Psychiatry. 2010;25(5):275–7. https://doi.org/10.1016/j.eurpsy.2009.12.012.

    Article  CAS  PubMed  Google Scholar 

  14. Martinez-Levy GA, Campos AI, Rabinowitz JA, Garcia-Marin LM, Benjet C, Mendez E, Renteria ME, Cruz-Fuentes CS. Suicidal ideation and planning among Mexican adolescents are associated with depression polygenic risk scores. Am J Med Genet B. 2021;186(8):476–84. https://doi.org/10.1002/ajmg.b.32864.

    Article  Google Scholar 

  15. Mullins N, Bigdeli TB, Borglum AD, Coleman JRI, Demontis D, Mehta D, Power RA, Ripke S, Stahl EA, Starnawska A, et al. GWAS of Suicide Attempt in Psychiatric Disorders and Association with Major Depression Polygenic Risk scores. Am J Psychiatry. 2019;176(8):651–60. https://doi.org/10.1176/appi.ajp.2019.18080957.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Elder BL, Mosack V. Genetics of depression: an overview of the current science. Issues Ment Health Nurs. 2011;32(4):192–202. https://doi.org/10.3109/01612840.2010.541588.

    Article  PubMed  Google Scholar 

  17. Mandelli L, Antypa N, Nearchou FA, Vaiopoulos C, Stefanis CN, Serretti A, Stefanis NC. The role of serotonergic genes and environmental stress on the development of depressive symptoms and neuroticism. J Affect Disord. 2012;142(1–3):82–9. https://doi.org/10.1016/j.jad.2012.03.047.

    Article  CAS  PubMed  Google Scholar 

  18. Arango V, Ernsberger P, Marzuk PM, Chen JS, Tierney H, Stanley M, Reis DJ, Mann JJ. Autoradiographic demonstration of increased serotonin 5-HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychiatry vol. 1990;47:1038–47.

    Article  CAS  Google Scholar 

  19. Hrdina PD, Demeter E, Vu TB, Sótónyi P, Palkovits M. 5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: increase in 5-HT2 sites in cortex and amygdala. Brain Res. 1993;614(1–2):37–44. https://doi.org/10.1016/0006-8993(93)91015-k.

    Article  CAS  PubMed  Google Scholar 

  20. Hrdina PD, Bakish D, Ravindran A, Chudzik J, Cavazzoni P, Lapierre YD. Platelet serotonergic indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatment. Psychiatry Res. 1997;66(2–3):73–85. https://doi.org/10.1016/s0165-1781(96)03046-6.

    Article  CAS  PubMed  Google Scholar 

  21. Lee BH, Lee SW, Yoon D, Lee HJ, Yang JC, Shim SH, Kim DH, Ryu SH, Han C, Kim YK. Increased plasma nitric oxide metabolites in suicide attempters. Neuropsychobiology. 2006;53(3):127–32. https://doi.org/10.1159/000092542.

    Article  CAS  PubMed  Google Scholar 

  22. González-Castro TB, Genis-Mendoza AD, Tovilla-Zárate CA, Juárez-Rojop IE, López-Narvaez ML, Pérez-Hernández N, Rodríguez-Pérez JM, Martínez-Magaña JJ. Association between polymorphisms of NOS1, NOS2 and NOS3 genes and suicide behavior: a systematic review and meta-analysis. Metab Brain Dis. 2019;34(4):967–77. https://doi.org/10.1007/s11011-019-00406-3.

    Article  CAS  PubMed  Google Scholar 

  23. Karolewicz B, Szebeni K, Stockmeier CA, Konick L, Overholser JC, Jurjus G, Roth BL, Ordway GA. Low nNOS protein in the locus coeruleus in major depression. J Neurochem. 2004;91(5):1057–66. https://doi.org/10.1111/j.1471-4159.2004.02792.x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Gao SF, Qi XR, Zhao J, Balesar R, Bao AM, Swaab DF. Decreased NOS1 expression in the anterior cingulate cortex in depression. Cereb Cortex. 2013;23(12):2956–64. https://doi.org/10.1093/cercor/bhs285.

    Article  PubMed  Google Scholar 

  25. Rolls ET, Cheng W, Gong W, Qiu J, Zhou C, Zhang J, Lv W, Ruan H, Wei D, Cheng K, et al. Functional connectivity of the Anterior Cingulate Cortex in Depression and in Health. Cereb Cortex. 2019;29(8):3617–30. https://doi.org/10.1093/cercor/bhy236.

    Article  PubMed  Google Scholar 

  26. Cooper B. Nature, nurture and mental disorder: old concepts in the new millennium. Br J Psychiatry Suppl. 2001;40:s91–101. https://doi.org/10.1192/bjp.178.40.s91.

    Article  CAS  PubMed  Google Scholar 

  27. Yang C, Sun N, Liu Z, Li X, Xu Y, Zhang K. The interaction of combined effects of the BDNF and PRKCG genes and negative life events in major depressive disorder. Psychiatry Res. 2016;237:72–7. https://doi.org/10.1016/j.psychres.2016.01.076.

    Article  CAS  PubMed  Google Scholar 

  28. Jokela M, Lehtimaki T, Keltikangas-Jarvinen L. The influence of urban/rural residency on depressive symptoms is moderated by the serotonin receptor 2A gene. Am J Med Genet B. 2007;144b(7):918–22. https://doi.org/10.1002/ajmg.b.30555.

    Article  CAS  Google Scholar 

  29. Roy A, Sarchiopone M, Carli V. Gene-Environment Interaction and suicidal behavior. J Psychiatr Pract. 2009;15(4):282–8. https://doi.org/10.1097/01.pra.0000358314.88931.b5.

    Article  PubMed  Google Scholar 

  30. Saveanu RV, Nemeroff CB. Etiology of depression: genetic and environmental factors. Psychiatr Clin North Am. 2012;35(1):51–71. https://doi.org/10.1016/j.psc.2011.12.001.

    Article  PubMed  Google Scholar 

  31. Ben-Efraim Y, Wasserman D, Wasserman J, Sokolowski M. Family-based study of HTR2A in suicide attempts: observed gene, gene x environment and parent-of-origin associations. Mol Psychiatr. 2013;18(7):758–66. https://doi.org/10.1038/mp.2012.86.

    Article  CAS  Google Scholar 

  32. Bukh JD, Bock C, Vinberg M, Werge T, Gether U, Kessing LV. Interaction between genetic polymorphisms and stressful life events in first episode depression. J Affect Disorders. 2009;119(1–3):107–15. https://doi.org/10.1016/j.jad.2009.02.023.

    Article  CAS  PubMed  Google Scholar 

  33. Murphy TM, Ryan M, Foster T, Kelly C, McClelland R, O’Grady J, Corcoran E, Brady J, Reilly M, Jeffers A, et al. Risk and protective genetic variants in suicidal behaviour: association with SLC1A2, SLC1A3, 5-HTR1B &NTRK2 polymorphisms. Behav Brain Funct. 2011;7:22. https://doi.org/10.1186/1744-9081-7-22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Dressler WW, Balieiro MC, Ribeiro RP, Dos Santos JE. Cultural consonance, a 5HT2A receptor polymorphism, and depressive symptoms: a longitudinal study of gene x culture interaction in urban Brazil. Am J Hum Biol. 2009;21(1):91–7. https://doi.org/10.1002/ajhb.20823.

    Article  PubMed  Google Scholar 

  35. Brezo J, Bureau A, Merette C, Jomphe V, Barker ED, Vitaro F, Hebert M, Carbonneau R, Tremblay RE, Turecki G. Differences and similarities in the serotonergic diathesis for suicide attempts and mood disorders: a 22-year longitudinal gene-environment study. Mol Psychiatry. 2010;15(8):831–43. https://doi.org/10.1038/mp.2009.19.

    Article  CAS  PubMed  Google Scholar 

  36. Lou XY, Chen GB, Yan L, Ma JZ, Zhu J, Elston RC, Li MD. A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence. Am J Hum Genet. 2007;80(6):1125–37. https://doi.org/10.1086/518312.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Kalin NH. Insights into suicide and depression. Am J Psychiat. 2020;177(10):877–80. https://doi.org/10.1176/appi.ajp.2020.20081207.

    Article  PubMed  Google Scholar 

  38. Docherty AR, Shabalin AA, DiBlasi E, Monson E, Mullins N, Adkins DE, Bacanu SA, Bakian AV, Crowell S, Chen D, et al. Genome-Wide Association Study of Suicide Death and polygenic prediction of clinical antecedents. Am J Psychiatry. 2020;177(10):917–27. https://doi.org/10.1176/appi.ajp.2020.19101025.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Shinozaki G, Romanowicz M, Mrazek DA, Kung S. HTR2A gene-child abuse interaction and association with a history of suicide attempt among caucasian depressed psychiatric inpatients. J Affect Disorders. 2013;150(3):1200–3. https://doi.org/10.1016/j.jad.2013.05.028.

    Article  CAS  PubMed  Google Scholar 

  40. Gonzalez-Castro TB, Genis-Mendoza AD, Tovilla-Zarate CA, Juarez-Rojop IE, Lopez-Narvaez ML, Perez-Hernandez N, Rodriguez-Perez JM, Martinez-Magana JJ. Association between polymorphisms of NOS1, NOS2 and NOS3 genes and suicide behavior: a systematic review and meta-analysis. Metab Brain Dis. 2019;34(4):967–77. https://doi.org/10.1007/s11011-019-00406-3.

    Article  CAS  PubMed  Google Scholar 

  41. Fanelli G, Serretti A. The influence of the serotonin transporter gene 5-HTTLPR polymorphism on suicidal behaviors: a meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2019;88:375–87. https://doi.org/10.1016/j.pnpbp.2018.08.007.

    Article  CAS  PubMed  Google Scholar 

  42. Hofer P, Schosser A, Calati R, Serretti A, Massat I, Kocabas NA, Konstantinidis A, Mendlewicz J, Souery D, Zohar J, et al. The impact of serotonin receptor 1A and 2A gene polymorphisms and interactions on suicide attempt and suicide risk in depressed patients with insufficient response to treatment–a European multicentre study. Int Clin Psychopharmacol. 2016;31(1):1–7. https://doi.org/10.1097/YIC.0000000000000101.

    Article  PubMed  Google Scholar 

  43. Seo HJ, Song HR, Yim HW, Kim JB, Lee MS, Kim JM, Jun TY. Age-related differences in suicidality between young people and older adults with depression: data from a nationwide depression cohort study in Korea (the CRESCEND study). Compr Psychiat. 2015;56:85–92. https://doi.org/10.1016/j.comppsych.2014.10.003.

    Article  PubMed  Google Scholar 

  44. Antypa N, Calati R, Souery D, Pellegrini S, Sentissi O, Amital D, Moser U, Montgomery S, Kasper S, Zohar J, et al. Variation in the HTR1A and HTR2A genes and social adjustment in depressed patients. J Affect Disord. 2013;150(2):649–52. https://doi.org/10.1016/j.jad.2013.02.036.

    Article  CAS  PubMed  Google Scholar 

  45. Gonzalez-Castro TB, Tovilla-Zarate C, Juarez-Rojop I, Pool Garcia S, Velazquez-Sanchez MP, Genis A, Nicolini H, Lopez Narvaez L. Association of the 5HTR2A gene with suicidal behavior: case-control study and updated meta-analysis. BMC Psychiatry. 2013;13:25. https://doi.org/10.1186/1471-244X-13-25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Mirkovic B, Cohen D, Laurent C, Lasfar M, Marguet C, Gerardin P. A case-control association study of 12 candidate genes and attempted suicide in French adolescents. Int J Adolesc Med Health. 2017;32(1). https://doi.org/10.1515/ijamh-2017-0089.

  47. Rujescu D, Giegling I, Mandelli L, Schneider B, Hartmann AM, Schnabel A, Maurer K, Moller HJ, Serretti A. NOS-I and -III gene variants are differentially associated with facets of suicidal behavior and aggression-related traits. Am J Med Genet B Neuropsychiatr Genet. 2008;147B(1):42–8. https://doi.org/10.1002/ajmg.b.30569.

    Article  CAS  PubMed  Google Scholar 

  48. Cui H, Supriyanto I, Asano M, Ueno Y, Nagasaki Y, Nishiguchi N, Shirakawa O, Hishimoto A. A common polymorphism in the 3 ‘-UTR of the NOS1 gene was associated with completed suicides in Japanese male population. Prog Neuro-Psychoph. 2010;34(6):992–6. https://doi.org/10.1016/j.pnpbp.2010.04.028.

    Article  CAS  Google Scholar 

  49. Choo C, Diederich J, Song I, Ho R. Cluster analysis reveals risk factors for repeated suicide attempts in a multi-ethnic Asian population. Asian J Psychiatr. 2014;8:38–42. https://doi.org/10.1016/j.ajp.2013.10.001.

    Article  PubMed  Google Scholar 

  50. Hawton K, Casanas ICC, Haw C, Saunders K. Risk factors for suicide in individuals with depression: a systematic review. J Affect Disord. 2013;147(1–3):17–28. https://doi.org/10.1016/j.jad.2013.01.004.

    Article  PubMed  Google Scholar 

  51. Zhang YQ, Yuan GZ, Li GL, Yao JJ, Cheng ZH, Chu X, Liu CJ, Liu QH, Wang AR, Shi GZ, et al. [A case-control study on the risk factors for attempted suicide in patients with major depression]. Zhonghua Liu Xing Bing Xue Za Zhi. 2007;28(2):131–5.

    PubMed  Google Scholar 

  52. Claassen CA, Trivedi MH, Rush AJ, Husain MM, Zisook S, Young E, Leuchter A, Wisniewski SR, Balasubramani GK, Alpert J. Clinical differences among depressed patients with and without a history of suicide attempts: findings from the STAR*D trial. J Affect Disorders. 2007;97(1–3):77–84. https://doi.org/10.1016/j.jad.2006.05.026.

    Article  PubMed  Google Scholar 

  53. Azorin JM, Kaladjian A, Besnier N, Adida M, Hantouche E, Lancrenon S, Akiskal H. Suicidal behaviour in a French cohort of major depressive patients: characteristics of attempters and nonattempters. J Affect Disord. 2010;123(1–3):87–94. https://doi.org/10.1016/j.jad.2009.09.004.

    Article  PubMed  Google Scholar 

  54. Gournellis R, Tournikioti K, Touloumi G, Thomadakis C, Michalopoulou PG, Michopoulos I, Christodoulou C, Papadopoulou A, Douzenis A. Psychotic (delusional) depression and completed suicide: a systematic review and meta-analysis. Ann Gen Psychiatry. 2018;17:39. https://doi.org/10.1186/s12991-018-0207-1.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Roy A. Frontiers in Neuroscience Gene–Environment Interaction and Suicidal Behavior. In: The Neurobiological Basis of Suicide edn. Edited by Dwivedi Y. Boca Raton (FL): CRC Press/Taylor & Francis © 2012 by Taylor & Francis Group, LLC.; 2012.

  56. Paykel ES. Life stress, depression and attempted suicide. J Hum Stress. 1976;2(3):3–12. https://doi.org/10.1080/0097840X.1976.9936065.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Thanks to all the patients who participated in this study. Thanks to my colleagues for their help in this study.

Funding

This work was supported by the National Natural Science Foundation of China (81371494) and the Provincial and Ministry Co-construction Funds of Henan Provincial Health Commission (SB201901012).

Author information

Authors and Affiliations

  1. Department of Psychiatry, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, 450052, Zhengzhou, China

    Jian-Yue Pang, Yi-Ping Wang, Hui-Min Teng, Jin He, Rui Luo, Si-Meng Feng & Heng-Fen Li

  2. Peking University Sixth Hospital, Peking University Institute of Mental Health, 100191, Beijing, China

    Wei-Hua Yue

  3. National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), 100191, Beijing, China

    Wei-Hua Yue

  4. NHC Key Laboratory of Mental Health (Peking University), 100191, Beijing, China

    Wei-Hua Yue

  5. PKU-IDG/McGovern Institute for Brain Research, Peking University, 100871, Beijing, China

    Wei-Hua Yue

  6. Chinese Institute for Brain Research, Beijing102206, China

    Wei-Hua Yue

Authors
  1. Jian-Yue Pang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yi-Ping Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hui-Min Teng
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jin He
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rui Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Si-Meng Feng
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Wei-Hua Yue
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Heng-Fen Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Conceived and designed the experiments: H.F. Li and W.H. Yue. Performed the experiments: H.M. Teng, J. He, R. Luo and S.M. Feng. Analyzed the data: J.Y. Pang and Y.P. Wang. Wrote the paper: J.Y. Pang. All authors contributed to and have approved the final manuscript.

Corresponding authors

Correspondence to Wei-Hua Yue or Heng-Fen Li.

Ethics declarations

Ethics approval and consent to participate

This study was conducted per the guidelines of the Declaration of Helsinki and was approved by the Ethics Committee of the First Affiliated Hospital of Zhengzhou University (approval number: 2013-LW-1282). All participants signed an informed consent form before they participated in the study.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Supplementary Material 2

Supplementary Material 3

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pang, JY., Wang, YP., Teng, HM. et al. Interaction between HTR2A rs3125 and negative life events in suicide attempts among patients with major depressive disorder: a cross-sectional study. BMC Psychiatry 24, 249 (2024). https://doi.org/10.1186/s12888-024-05713-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12888-024-05713-3

Keywords

BMC Psychiatry

ISSN: 1471-244X

Contact us